| Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat (NCT04644705) | Charité Research Organisation GmbH | 2020-11-02 |
| Cysteine-lowering Treatment With Mesna (NCT04449536) | University of Oslo | 2020-11-02 |
| Study to Evaluate the Safety and Tolerability of EP0042 (NCT04581512) | Ellipses Pharma | 2020-11-02 |
| Minnelide™ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer (NCT05566834) | Minneamrita Therapeutics LLC | 2020-11-02 |
| A Study of LY3832479 (LY-CoV016) in Healthy Participants 1 (NCT04611789) | Eli Lilly and Company | 2020-11-02 |
| Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System (NCT04450563) | McGill University | 2020-11-02 |
| A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008) (NCT06444204) | Principia Biopharma, a Sanofi Company | 2020-11-02 |
| Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older (NCT04622592) | Medicago | 2020-11-02 |
| Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC (NCT04507906) | Shanghai Chest Hospital | 2020-11-02 |
| Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease (NCT04624490) | Mario Castro, MD, MPH | 2020-11-02 |
| A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients (NCT04581343) | Pancreatic Cancer Action Network | 2020-11-02 |
| Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. (NCT04519476) | Oncotherapeutics | 2020-11-01 |
| Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection (NCT03619278) | Judit Pich | 2020-11-01 |
| Using Travelan to Boost Immune Response in Vitro to COVID-19 (NCT04643561) | Hadassah Medical Organization | 2020-11-01 |
| Human Placental Mesenchymal Stem Cells Treatment on Diabetic Foot Ulcer (NCT04464213) | Beijing Tongren Hospital | 2020-11-01 |
| Bioavailability of Nasal Epinephrine (NCT04696822) | Nasus Pharma | 2020-11-01 |
| Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions (NCT05433896) | Xspray Pharma AB | 2020-11-01 |
| Efficacy of Percutaneous SPG Block in Aneurysmal SAH (NCT04331938) | Mayo Clinic | 2020-11-01 |
| The Interaction of Flavor With Nicotine Form in Adult Smokers (NCT04262817) | Yale University | 2020-11-01 |
| Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery (NCT02607488) | Mansoura University | 2020-11-01 |
| A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC (NCT04521075) | Ella Therapeutics Ltd | 2020-11-01 |
| A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease (NCT05016427) | VTBIO Co. LTD | 2020-11-01 |
| Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection (NCT04629287) | Kunming Pharmaceuticals, Inc. | 2020-11-01 |
| Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults (NCT04663139) | YSOPIA Bioscience | 2020-11-01 |
| Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (NCT04590274) | International Brain Research Foundation | 2020-11-01 |
| PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries (NCT04594629) | Ain Shams University | 2020-11-01 |
| Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer (NCT04205071) | Ohio State University Comprehensive Cancer Center | 2020-11-01 |
| Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis (NCT04583488) | Johns Hopkins University | 2020-11-01 |
| The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin (NCT04601077) | Nitric Oxide Innovations LLC | 2020-11-01 |
| A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers (NCT04627207) | Chong Kun Dang Pharmaceutical | 2020-11-01 |
| Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study (NCT04262089) | University Medical Center Groningen | 2020-11-01 |
| A Trial of SHR-1819 in Healthy Subjects (NCT04561128) | Atridia Pty Ltd. | 2020-11-01 |
| Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors (NCT04611711) | Peking University | 2020-11-01 |
| Oral Cannabidiol for Opioid Withdrawal (NCT04238754) | Johns Hopkins University | 2020-11-01 |
| The Effects of Low Dose Ketamine on Cardiovascular Function (NCT04429685) | University of Texas Southwestern Medical Center | 2020-11-01 |
| Development of a Robotic Ankle Assist Device (NCT04516343) | BiOMOTUM, Inc. | 2020-11-01 |
| A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver) (NCT04524871) | Hoffmann-La Roche | 2020-11-01 |
| PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity (NCT04621136) | Kyushu University | 2020-11-01 |
| Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis (NCT04493294) | International Geriatric Radiotherapy Group | 2020-11-01 |
| Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma (NCT03880123) | Matthew Ingham | 2020-11-01 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 (NCT04551547) | Sinovac Research and Development Co., Ltd. | 2020-10-31 |
| Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia (NCT04460105) | Shire | 2020-10-31 |
| Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) (NCT03888534) | Millennium Pharmaceuticals, Inc. | 2020-10-31 |
| Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors (NCT04630522) | Shanghai JMT-Bio Inc. | 2020-10-31 |
| Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects (NCT04598607) | Zhejiang Huahai Pharmaceutical Co., Ltd. | 2020-10-30 |
| A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets (NCT04601766) | Asieris Pharmaceuticals (AUS) Pty Ltd. | 2020-10-30 |
| Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer (NCT07504484) | Ying Yuan, MD | 2020-10-30 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants (NCT04472897) | GlaxoSmithKline | 2020-10-30 |
| Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine (NCT04672473) | Shenzhen University General Hospital | 2020-10-30 |
| CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study (NCT04552704) | Tianhong Li | 2020-10-30 |
| Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) (NCT04636333) | Jiangsu Province Centers for Disease Control and Prevention | 2020-10-30 |
| A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome (NCT04608110) | Taiho Pharmaceutical Co., Ltd. | 2020-10-30 |
| A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma (NCT04655677) | Peking Union Medical College Hospital | 2020-10-30 |
| Study of NKTR 255 in Combination With Cetuximab in Solid Tumors (NCT04616196) | Nektar Therapeutics | 2020-10-30 |
| JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects (NCT04780321) | Shanghai Junshi Bioscience Co., Ltd. | 2020-10-30 |
| Lanadelumab for Treatment of COVID-19 Disease (NCT04422509) | Radboud University Medical Center | 2020-10-30 |
| Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment (NCT04587622) | Novartis Pharmaceuticals | 2020-10-30 |
| A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV) (NCT04535752) | Annexon, Inc. | 2020-10-30 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants (NCT04593121) | Biogen | 2020-10-30 |
| LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) (NCT04446962) | Institut Curie | 2020-10-30 |
| First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors (NCT04622774) | ImmunoGen, Inc. | 2020-10-29 |
| Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma (NCT05777707) | Beijing Friendship Hospital | 2020-10-29 |
| A Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian Adults (NCT04580654) | CSL Behring | 2020-10-29 |
| Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma (NCT04528680) | Northwestern University | 2020-10-29 |
| Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release (NCT04873011) | Universitaire Ziekenhuizen KU Leuven | 2020-10-29 |
| Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download (NCT05346380) | Massachusetts General Hospital | 2020-10-29 |
| Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions (NCT04678388) | Chong Kun Dang Pharmaceutical | 2020-10-29 |
| A Study to Evaluate the Safety and Efficacy of MGD013 in Patients With Melanoma (NCT04653038) | Zai Lab (Shanghai) Co., Ltd. | 2020-10-29 |
| Blood-Brain Barrier Penetration of Therapeutic Agents in Human (NCT04571996) | Orion Corporation, Orion Pharma | 2020-10-29 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects (NCT04351165) | Impact Therapeutics, Inc. | 2020-10-29 |
| Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease (NCT04541407) | University of Colorado, Denver | 2020-10-29 |
| A Study of PY314 in Subjects With Advanced Solid Tumors (NCT04691375) | Ikena Oncology | 2020-10-29 |
| Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) (NCT04569786) | Merck Sharp & Dohme LLC | 2020-10-29 |
| A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects (NCT04508179) | 7 Hills Pharma, LLC | 2020-10-28 |
| Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration (NCT04567303) | Hoffmann-La Roche | 2020-10-28 |
| Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine (NCT04608305) | Israel Institute for Biological Research (IIBR) | 2020-10-28 |
| Detection of PitNET Tissue During TSS Using Bevacizumab-800CW (NCT04212793) | University Medical Center Groningen | 2020-10-28 |
| Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress (NCT04606784) | Ampio Pharmaceuticals. Inc. | 2020-10-28 |
| Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects (NCT05526690) | AstraZeneca | 2020-10-28 |
| Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke (NCT04734548) | aptaTargets S.L. | 2020-10-28 |
| Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients (NCT04497389) | University of Utah | 2020-10-28 |
| Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease (NCT04519684) | Anthony Lembo | 2020-10-28 |
| A Phase I Study of JS108 in Patients With Advanced Solid Tumors (NCT04601285) | Shanghai Junshi Bioscience Co., Ltd. | 2020-10-28 |
| Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR) (NCT04630002) | ViiV Healthcare | 2020-10-28 |
| A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas (NCT04551352) | Hoffmann-La Roche | 2020-10-28 |
| A Study to Evaluate the Safety, Tolerability, and Fecal Pharmacokinetics of BX002-A in Healthy Adults (NCT04737876) | BiomX, Inc. | 2020-10-28 |
| Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease (NCT04519697) | Anthony Lembo | 2020-10-28 |
| A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants (NCT04609852) | Eisai Co., Ltd. | 2020-10-28 |
| A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013) (NCT04521621) | Merck Sharp & Dohme LLC | 2020-10-28 |
| Gene Transfer Study in Patients With Late Onset Pompe Disease (NCT04174105) | Astellas Gene Therapies | 2020-10-27 |
| Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC (NCT06001671) | Hunan Province Tumor Hospital | 2020-10-27 |
| Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. (NCT04652206) | Scandion Oncology A/S | 2020-10-27 |
| Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-endemic Participants in Cambodia (NCT04350905) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-10-27 |
| Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions (NCT04651881) | Chong Kun Dang Pharmaceutical | 2020-10-27 |
| A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants (NCT04578535) | Baxalta now part of Shire | 2020-10-27 |
| Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors (NCT04222413) | National Cancer Institute (NCI) | 2020-10-27 |
| Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma (NCT04231877) | University of Washington | 2020-10-27 |
| Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) (NCT04610567) | University of Sao Paulo General Hospital | 2020-10-27 |
| Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer (NCT04619069) | Sunnybrook Health Sciences Centre | 2020-10-27 |